Delivery Order SPE2DB20D3303-SPE2DB25FA2GW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4 mL units, with a ceiling value of $1,950.24 and an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a continuation of the company's pharmaceutical supply mission supporting federal medical procurement. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a $1,392.18 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4mL units, with an ultimate completion date of September 16, 2025. This non-set-aside delivery order will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfilled this...
- The Defense Logistics Agency awarded a delivery order valued at $1,582.65 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution 4ML, a pharmaceutical product for military medical supply needs. This competitively awarded, firm fixed price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.68 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4 mL units, with an ultimate completion date of July 28, 2025. This contract award is not set-aside and utilizes firm fixed pricing under a competitive delivery order arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.68 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4 milliliter units. This firm fixed price delivery order, executed on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,988,146 units of 0.5% Tetracaine Steri-Unit Solution (4 mL). The contract has an ultimate completion date of March 18, 2024 and a ceiling value of $3,087.08. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value...
- The Defense Logistics Agency awarded a $977.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562322788 tetracaine 0.5% steri-unit solution 4ml. The single award was issued against an existing DLA pharmaceuticals contract vehicle and will be performed by Amerisourcebergen at its Conshohocken, Pennsylvania facility through September 28, 2023. As a major distributor of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for a...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $1,746.68 to Amerisourcebergen Drug Corporation for the supply of 4562115821 Tetracaine 0.5% Steri-Unit Sol 4ml to be delivered to a location in Conshohocken, Pennsylvania between September 8-11, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this contract issued against an unspecified government-wide acquisition...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 0.5% tetracaine sterile solution products. The $1,744.20 award has a period of performance through March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4 mL vials of 0.5% Tetracaine sterile solution. The $3,019.24 contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2GWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4 ml quantities, with a ceiling value of $1,918.80 and an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the awardee's Conshohocken, Pennsylvania facility. The contract represents a small-value transaction typical of the Defense Logistics Agency's medical supply operations, fulfilling pharmaceutical procurement needs for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The company's designation as a prime vendor demonstrates its capability to meet federal procurement requirements through competitive procurement processes, supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/7/25 |